Search

everythinglearnresearchcommunity

for

Search:↓

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Targeting specific cell interactions may help treat skin fibrosis.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Entospletinib effectively prevents eye and skin GVHD in mice.

The combination treatment showed a higher response rate but no significant survival benefits.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Cetuximab can cause eyelash growth, which is rare but manageable.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Early diagnosis and treatment are crucial for managing Berardinelli–Seip syndrome.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Cepharanthine may help hair growth by increasing IGF-I in scalp cells.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Cetuximab can cause excessive eyelash growth.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Erlotinib can cause excessive eyelash growth.

CTP-543 is generally safe for treating alopecia areata.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.